PEP
41
-7
MTB
53
-4
HST
52
-2
NTAP
46
3
CCL
67
2
V
40
2
CME
46
3
AIV
51
3
FLS
55
3
KMB
42
2
AVB
45
3
ED
45
3
XRX
44
3
EQT
54
4
MSI
57
5
SWK
39
-10
WYNN
45
-3
STT
50
5
ROK
71
3
SO
51
3
PEP
41
-7
MTB
53
-4
HST
52
-2
NTAP
46
3
CCL
67
2
V
40
2
CME
46
3
AIV
51
3
FLS
55
3
KMB
42
2
AVB
45
3
ED
45
3
XRX
44
3
EQT
54
4
MSI
57
5
SWK
39
-10
WYNN
45
-3
STT
50
5
ROK
71
3
SO
51
3
Financhill
Back

Replimune Group Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64

REPL
Replimune Group

Last Price:
$12.64
Seasonality Move:
-4.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Replimune Group Stock Forecast

  • Over the next 52 weeks, Replimune Group has on average historically risen by 5.2% based on the past 6 years of stock performance.
  • Replimune Group has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Replimune Group Stock Undervalued?
    The current Replimune Group [REPL] share price is $12.63. The Score for REPL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • REPL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Replimune Group Stock Go Up Next Year?

  • Over the next 52 weeks, Replimune Group has on average historically risen by 5.2% based on the past 6 years of stock performance.

Replimune Group Stock Rating

Buy
64
Replimune Group (REPL) is a Buy

Is Replimune Group overpriced?

  • Replimune Group has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Replimune Group Stock Price History

Is REPL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
replimune.com

52-Week Data

52-Week High:
17.00
52-Week Low:
6.44

Prediction Charts

Market Cap:
973.6M
Price in USD:
12.63
Volume:
4.1M
Beta:
1.61

Technical Analysis

SMA50:
9.29
SMA100:
9.77
SMA200:
11.03
52-Wk Change:
14.2%

Stock Predictions

  • Is Replimune Group stock public?
    Yes, Replimune Group is a publicly traded company.
  • What is the Replimune Group stock quote today?
    The Replimune Group stock price is 12.63 USD today.
  • How to buy Replimune Group stock online?
    You can buy Replimune Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 9.53 9.46 9.78 9.23
Jun-27 9.48 9.33 9.57 9.16
Jun-30 9.45 9.29 9.64 9.15
Jul-1 9.27 9.15 9.73 9.12
Jul-2 9.15 9.55 9.70 9.15
Jul-3 9.70 9.40 9.79 9.31
Jul-7 9.51 9.65 9.90 9.37
Jul-8 9.64 9.34 9.89 9.26
Jul-9 9.47 10.39 10.41 9.40
Jul-10 10.50 10.77 10.84 10.20
Jul-11 10.85 10.97 11.29 10.65
Jul-14 10.94 11.28 11.41 10.83
Jul-15 11.47 12.40 12.43 11.24
Jul-16 13.19 12.63 13.19 12.03

Replimune Group Earnings

Replimune Group Earnings Report: Per Share Replimune Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

Replimune Group Forecast Revenue Growth

Replimune Group Stock Analysis: Historical quarterly revenues per share for Replimune Group and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.06 per share, an increase this year of $0.35 per share, and an increase next year of $0.00 per share.

* Replimune Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.